IP Library Granted Patent US 11,346,844
Granted Patent B2
US 11,346,844 · App. 16/859,758 · Granted May 31, 2022

Intact mass reconstruction from peptide level data and facilitated comparison with experimental intact observation

Inventors: Andrew Nichols (Redwood City, CA); Marshall Bern (San Carlos, CA); Yong Joo Kil (San Bruno, CA); Eric Carlson (Cupertino, CA)
Assignee: Protein Metrics Inc.
G01N33/6848H01J49/0036H01J49/004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,346,844
App. No.
16/859,758
Granted
May 31, 2022
Kind
B2
Abstract

Methods and apparatuses for the identification and/or characterization of properties of a macromolecule based on mass spectrometry data. Specifically, described herein are methods and apparatuses for converting peptide-level data into a pseudo-intact mass spectra. Also described herein are methods and apparatuses for converting peptide-level data into a pseudo-electropherogram. The methods may be well suited for analyzing proteins and protein complexes, including estimating properties of post-translational modifications of the proteins and protein complexes. Methods may include generating a theoretical graph or spectrum based on peptide-level mass spectrometry data. In some embodiments, the theoretical graph may be a theoretical intact mass spectrum or a theoretical charge distribution spectrum.

Claims (30)

1. A method for reconstructing an intact mass spectrum of a protein or protein complex from peptide level data to form a pseudo intact mass spectrum of the protein or protein complex, the method comprising:

receiving mass spectrum data associated with peptides of an enzyme-digested sample of the protein or protein complex, wherein the mass spectrum data includes mass-to-charge ratio data associated with a set of modified peptide forms in the enzyme-digested sample;

receiving, from a user, a selection of one or more modified peptide forms to include or to remove from the pseudo intact mass spectrum, wherein the selection is made from the set of modified peptide forms;

generating the pseudo intact mass spectrum of the protein or protein complex from all or a subset of the received mass spectrum data, based on the selected one or more modified peptide forms to include or remove, wherein the pseudo intact mass spectrum is derived based in part on a comparison of the modified peptide forms to a reference list of peptide sequences; and

displaying an overlay of the intact mass spectrum of the protein and the pseudo intact mass spectrum of the protein or protein complex, wherein differences between the intact mass spectrum and the pseudo intact mass spectrum are highlighted.

2. The method of claim 1 , wherein the one or more modified peptide forms include one or more modification groups, the one or more modification groups including one or more of a glycan group, a phosphate group, an amino group and a carboxyl group.

3. The method of claim 1 , further comprising iteratively receiving one or more modified peptide forms to include or to remove from the pseudo intact mass spectrum, generating a modified pseudo intact mass spectrum including or removing the received one or more modified peptide forms to include or to remove, and displaying the modified pseudo intact mass spectrum.

4. The method of claim 3 , wherein displaying the modified pseudo intact mass spectrum comprises displaying an overlay of the intact mass spectrum of the protein and the modified pseudo intact mass spectrum of the protein or protein complex.

5. The method of claim 1 , further comprising displaying the set of modified peptide forms in a table, wherein the user may individually select the one or more modified peptide forms to include or to remove from the displayed set of modified peptide forms.

6. The method of claim 5 , wherein the table includes information with regard to one or more of: a protein corresponding to each modified peptide form, a position on the corresponding protein, a modification group, a modification group molecular weight, and an abundance of a modified peptide form.

7. The method of claim 1 , wherein the intact mass spectrum is a deconvoluted mass spectrum of the protein or protein complex.

8. The method of claim 1 , wherein the protein or protein complex comprises an antibody, wherein the enzyme-digested sample includes peptides from at least a heavy chain protein and a light chain protein of the antibody.

9. The method of claim 1 , wherein the intact mass spectrum is an experimentally derived intact mass spectrum.

10. The method of claim 1 , wherein displaying the overlay comprises overlaying the intact mass spectrum over the pseudo intact mass spectrum, overlaying the pseudo intact mass spectrum over the intact mass spectrum, or displaying the intact mass spectrum adjacent to the pseudo intact mass spectrum.

11. The method of claim 1 , wherein highlighting the differences comprises displaying the intact mass spectrum and the pseudo intact mass spectrum with different colors, symbols and/or labels.

12. The method of claim 1 , wherein displaying the overlay comprises displaying peak labels in one or both of the intact mass spectrum and the pseudo intact mass spectrum with a mass, a modification name and/or a modification group associated with a peak.

13. A system, the system comprising:

one or more processors;

memory coupled to the one or more processors, the memory configured to store computer-program instructions, that, when executed by the one or more processors, perform a computer-implemented method comprising:

receiving mass spectrum data associated with peptides of an enzyme-digested sample of a protein or protein complex, wherein the mass spectrum data includes mass-to-charge ratio data associated with a set of modified peptide forms in the enzyme-digested sample;

receiving, from a user, a selection of one or more modified peptide forms to include or to remove from a pseudo intact mass spectrum, wherein the selection is made from the set of modified peptide forms;

generating the pseudo intact mass spectrum of the protein or protein complex from all or a subset of the received mass spectrum data, based on the selected one or more modified peptide forms to include or remove, wherein the pseudo intact mass spectrum is derived based in part on a comparison of the modified peptide forms to a reference list of peptide sequences; and

displaying an overlay of an intact mass spectrum of the protein and the pseudo intact mass spectrum of the protein or protein complex, wherein differences between the intact mass spectrum and the pseudo intact mass spectrum are highlighted.

14. The method of claim 1 , wherein the pseudo intact mass spectrum is computed from a combination of measurements of one or more modified peptide forms.

15. The system of claim 13 , wherein the intact mass spectrum and the pseudo intact mass spectrum are displayed using one or more different colors, different symbols, different fonts, and different labels.

16. The system of claim 13 , wherein displaying the overlay includes displaying peak labels in one or both of the intact mass spectrum and the pseudo intact mass spectrum with one or more of a mass, a modification name, and a modification group associated with a peak.

17. The system of claim 13 , further comprising subtracting the intact mass spectrum from the pseudo intact mass spectrum, or subtracting the pseudo intact mass spectrum from the intact mass spectrum, and displaying a subtracted spectrum.

18. The system of claim 13 , further comprising aligning peaks of the intact mass spectrum and pseudo intact mass spectrum for displaying the overlay.

19. The system of claim 13 , wherein the pseudo intact mass spectrum is computed from a combination of measurements of one or more modified peptide forms.

20. The system of claim 13 , wherein displaying the overlay comprises overlaying the intact mass spectrum over the pseudo intact mass spectrum, overlaying the pseudo intact mass spectrum over the intact mass spectrum, or displaying the intact mass spectrum adjacent to the pseudo intact mass spectrum.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2025
From: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
To: PROTEIN METRICS, LLC; SOFTGENETICS, LLC
Reel/Frame 071582/0907 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2024
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: PROTEIN METRICS, INC.
Reel/Frame 067895/0115 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jul 1, 2024
From: PROTEIN METRICS, LLC; SOFTGENETICS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 068102/0180 →
TERMINATION OF PATENT SECURITY AGREEMENT AT REEL 58457/FRAME 0205 Recorded Jul 1, 2024
From: BARINGS FINANCE LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: PROTEIN METRICS, INC. (N/K/A PROTEIN METRICS, LLC)
Reel/Frame 068102/0310 →
CHANGE OF NAME Recorded Feb 8, 2023
From: PROTEIN METRICS INC.
To: PROTEIN METRICS, LLC
Reel/Frame 062625/0973 →
SECURITY INTEREST Recorded Dec 22, 2021
From: PROTEIN METRICS INC.
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 058457/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: NICHOLS, ANDREW; BERN, MARSHALL; KIL, YONG JOO; CARLSON, ERIC
To: PROTEIN METRICS INC.
Reel/Frame 054305/0385 →
Cited By (4)
US 12,205,331 US 12,224,169 US 12,352,757 US 12,400,846